CardioMEMS Registry of the Frankfurt Heart Failure Center
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Heart Failure
- Sponsor
- Johann Wolfgang Goethe University Hospital
- Enrollment
- 500
- Locations
- 2
- Primary Endpoint
- morbidity measured as worsening heart failure requiring hospitalisation and / or increase in diuretic dose
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
Invasive hemodynamic monitoring in advanced heart failure patients is a relative new option. In order to investigate the impact of remote telemonitoring of pulmonary artery pressures on mortality and morbidity in a routine clinical setting in Germany, the investigators initiated this multicenbtric registry.
Detailed Description
All patients who receive invasive hemodynamic monitoring using a pulmonary artery pressure sensor (CardioMEMS device) are offered participation in the registry. Routine heart-failure parameters, lab values, medication and QoL as obtained on the regular outpatients visits in the department are entered into a registry-specific database. The investigators plan to asses the impact of telemonitoring on mortality, morbidity and QoL as well as on Guideline-recommended heart failure medication. In addition, it is planned to quantify the input in person time for telemonitoring.
Investigators
Birgit Assmus, PD Dr.
Prof. Dr. med.
Johann Wolfgang Goethe University Hospital
Eligibility Criteria
Inclusion Criteria
- •Implantation of CardioMEMS successful
- •Telemonitoring according to the SOP of the Frankfurt Heart Failure Center (Goethe University)
Exclusion Criteria
- •Unwillingness to participate in the registry
Outcomes
Primary Outcomes
morbidity measured as worsening heart failure requiring hospitalisation and / or increase in diuretic dose
Time Frame: 5 years
morbidity